RESUMO
BACKGROUND: Acute asthma during pregnancy is potentially dangerous to the fetus. The aim of this study was to investigate the effect of an acute attack of asthma during pregnancy on the course of pregnancy or delivery, or the health of the newborn infant, and to identify undertreatment as a possible cause of the exacerbations. METHODS: Five hundred and four pregnant asthmatic subjects were prospectively followed and treated. The data on 47 patients with an attack of asthma during pregnancy were compared with those of 457 asthmatics with no recorded acute exacerbation and with 237 healthy parturients. RESULTS: Of 504 asthmatics, 177 patients were not initially treated with inhaled corticosteroids. Of these, 17% had an acute attack compared with only 4% of the 257 patients who had been on inhaled anti-inflammatory treatment from the start of pregnancy. There were no differences between the groups as to length of gestation, length of the third stage of labour, or amount of haemorrhage after delivery. No differences were observed between pregnancies with and without an exacerbation with regard to relative birth weight, incidence of malformations, hypoglycaemia, or need for phototherapy for jaundice during the neonatal period. CONCLUSIONS: Patients with inadequate inhaled anti-inflammatory treatment during pregnancy run a higher risk of suffering an acute attack of asthma than those treated with an anti-inflammatory agent. However, if the acute attack of asthma is relatively mild and promptly treated, it does not have a serious effect on the pregnancy, delivery, or the health of the newborn infant.
Assuntos
Anti-Inflamatórios/uso terapêutico , Asma/tratamento farmacológico , Beclometasona/uso terapêutico , Complicações na Gravidez/tratamento farmacológico , Doença Aguda , Adulto , Anti-Inflamatórios/efeitos adversos , Beclometasona/efeitos adversos , Peso ao Nascer , Broncodilatadores/efeitos adversos , Broncodilatadores/uso terapêutico , Budesonida , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Trabalho de Parto , Gravidez , Pregnenodionas/efeitos adversos , Pregnenodionas/uso terapêuticoRESUMO
Intrauterine hydrops was diagnosed by two dimensional echocardiography. The fetus had a pericardial effusion and a thick interatrial septum without a foramen ovale flap. The condition was treated by giving the mother digitalis. Postnatally, the effusion had disappeared and a parachute mitral valve was found.
Assuntos
Edema/etiologia , Doenças Fetais/etiologia , Defeitos dos Septos Cardíacos/complicações , Digitalis , Ecocardiografia , Edema/tratamento farmacológico , Feminino , Doenças Fetais/tratamento farmacológico , Humanos , Recém-Nascido , Plantas Medicinais , Plantas Tóxicas , Gravidez , Diagnóstico Pré-NatalRESUMO
Serum folate concentrations, blood counts, and antiepileptic drug concentrations were measured during 133 pregnancies of 125 women with epilepsy. There was an inverse correlation between serum folate concentrations and concentrations of phenytoin and phenobarbitone. The number of epileptic seizures during pregnancy showed no association with serum folate concentrations. No cases of maternal tissue folate deficiency or fetal damage attributable to low maternal serum folate were observed. Maternal serum folate concentrations for infants with structural birth defects, "fetal hydantoin syndrome," or perinatal death were similar to those for healthy babies. A low dose (100 to 1000 micrograms daily) of folate supplement appeared sufficient for pregnant women with epilepsy despite the antifolic action of antiepileptic medication. Monitoring folate concentrations in pregnant women with high serum concentrations of phenytoin or phenobarbitone is recommended.